Home › NDC Lookup › RxCUI directory › RxCUI 308511

Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment — RxCUI 308511

RxNorm drug concept · Semantic clinical drug
RxCUI 308511 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI308511
Official nameBacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbacitracin (as bacitracin zinc) 500 UNT / polymyxin B (as polymyxin B sulfate) 10,000 UNT per GM Ophthalmic Ointment; bacitracin zinc 500 UNT / polymyxin B sulfate 10,000 UNT per GM Ophthalmic Ointment
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)15,248 prescriptions · 41 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bacitracin Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's a first aid antibiotic you put directly on the skin to help prevent infection in minor cuts, scrapes, and burns. It's not meant for serious or deep wounds — just everyday smal...
  • What exactly is bacitracin topical used for?
  • Use a small amount — about the size of the tip of your finger — and apply it to the clean, dry area 1 to 3 times a day. You can put a sterile bandage over it if you like. Don't use...
  • Not without checking with your doctor first. Bacitracin topical is meant for minor wounds. Deep or puncture wounds, animal bites, and serious burns need a doctor's evaluation — thi...
📖 Read our full Bacitracin Topical guide →

🕸️ Concept Web — How Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Op... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment RxCUI 308511

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Bacitracin 1291
    • Polymyxin B 8536
    • Bacitracin / polymyxin B 645555
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Polycin 219307
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bacitracin / polymyxin B Ophthalmic Ointment 374629
    • Bacitracin / polymyxin B Ophthalmic Product 1155353
    • Bacitracin / polymyxin B Ophthalmic Ointment [Polycin] 367253
    • Polycin Ophthalmic Product 1183520
    • Ophthalmic Ointment 91344
    • Ophthalmic Product 1151135
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Bacitracin 0.5 UNT/MG SCDC · 315454
  • Polymyxin B 10 UNT/MG SCDC · 328475
  • Bacitracin / polymyxin B Ophthalmic Ointment SCDF · 374629
  • Bacitracin / polymyxin B Ophthalmic Product SCDG · 1155353

Brand-Name Concepts

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 308511 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
24208-0555-55 1 TUBE in 1 CARTON (24208-555-55) / 3.5 g in 1 TUBE Bacitracin Zinc and Polymyxin B Sulfate Bausch & Lomb Incorporated 2008-04-25
50090-3274-00 1 TUBE in 1 CARTON (50090-3274-0) / 3.5 g in 1 TUBE Bacitracin Zinc and Polymyxin B Sulfate A-S Medication Solutions 2017-11-21
50090-7189-00 144 TUBE in 1 CASE (50090-7189-0) / 3.5 g in 1 TUBE Bacitracin Zinc and Polymyxin B Sulfate A-S Medication Solutions 2024-07-02
66267-0925-35 3.5 g in 1 TUBE (66267-925-35) polycin NuCare Pharmaceuticals,Inc. 2017-11-06
68071-5267-03 3.5 g in 1 BOX (68071-5267-3) Bacitracin Zinc and Polymyxin B Sulfate NuCare Pharmaceuticals,Inc. 2020-06-03
Observed labelers: A-S Medication Solutions (2) · NuCare Pharmaceuticals,Inc. (2) · Bausch & Lomb Incorporated (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$2.6947
Range $2.6947–$2.6947 · middle 50% $2.6947–$2.6947 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.